Evidence map›Paper›PMID 25956706›Full record

ArticleDigestive diseases and sciences2015

Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn's Disease and Ulcerative Colitis.

Maria E C Bruno, Eric W Rogier, Razvan I Arsenescu, Deborah R Flomenhoft, Cathryn J Kurkjian, Gavin I Ellis, Charlotte S Kaetzel

Abstract readComparative Study
In one paragraph

Article in Digestive diseases and sciences, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. A20 in Kidney Transplantation and Autoimmunity.International journal of molecular sciences · 2024
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Role of Polymeric Immunoglobulin Receptor in IgA and IgM Transcytosis.International journal of molecular sciences · 2021
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Maria E C BrunoDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, 40536, USA. mebrun2@uky.edu.
Eric W RogierDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, 40536, USA. erogier@cdc.gov.
Razvan I ArsenescuDepartment of Internal Medicine, University of Kentucky, Lexington, KY, 40536, USA. arsenescu.1@osu.edu.
Deborah R FlomenhoftDepartment of Internal Medicine, University of Kentucky, Lexington, KY, 40536, USA. deborah.flomenhoft@uky.edu.
Cathryn J KurkjianDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, 40536, USA. ckurkjia@email.unc.edu.
Gavin I EllisDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, 40536, USA. gavellis@mail.med.upenn.edu.
Charlotte S KaetzelDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky, Lexington, KY, 40536, USA. cskaet@uky.edu.
University of Kentucky · US

Funding

UKY DENTAL COBRE: POLYBACTERIAL PERIODONTITIS: N-3 PUFA AND ANTIOXIDANTSP20RR020145 · NCRR · UNIVERSITY OF KENTUCKY · PI EBERSOLE, JEFFREY L · 2004 to 2011
$18.3M
OHPP Oral Health Pilot Program P30GM110788 · NIGMS · UNIVERSITY OF KENTUCKY · PI EBERSOLE, JEFFREY L · 2014 to 2018
$5.4M
Novel in vivo models for cell-type specific MyD88 signaling in the intestineR21AI069027 · NIAID · UNIVERSITY OF KENTUCKY · PI KAETZEL, CHARLOTTE S · 2007 to 2009
$524k
NCRR NIH HHS 5P20RR02014NCRR NIH HHS P20 RR020145NIAID NIH HHS AI069027NIAID NIH HHS R21 AI069027NIGMS NIH HHS P30 GM110788
6 · The paper itself

Abstract

backgroundInflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are characterized by chronic intestinal inflammation due to immunological, microbial, and environmental factors in genetically predisposed individuals. Advances in the diagnosis, prognosis, and treatment of IBD require the identification of robust biomarkers that can be used for molecular classification of diverse disease presentations. We previously identified five genes, RELA, TNFAIP3 (A20), PIGR, TNF, and IL8, whose mRNA levels in colonic mucosal biopsies could be used in a multivariate analysis to classify patients with CD based on disease behavior and responses to therapy.

aimWe compared expression of these five biomarkers in IBD patients classified as having CD or UC, and in healthy controls.

resultsPatients with CD were characterized as having decreased median expression of TNFAIP3, PIGR, and TNF in non-inflamed colonic mucosa as compared to healthy controls. By contrast, UC patients exhibited decreased expression of PIGR and elevated expression of IL8 in colonic mucosa compared to healthy controls. A multivariate analysis combining mRNA levels for all five genes resulted in segregation of individuals based on disease presentation (CD vs. UC) as well as severity, i.e., patients in remission versus those with acute colitis at the time of biopsy.

conclusionWe propose that this approach could be used as a model for molecular classification of IBD patients, which could further be enhanced by the inclusion of additional genes that are identified by functional studies, global gene expression analyses, and genome-wide association studies.

Indexed as

AdolescentAdultAgedChi-Square DistributionColitis, UlcerativeCrohn DiseaseDNA-Binding ProteinsFemaleGene ExpressionGenetic MarkersHumansInterleukin-8Intestinal MucosaIntracellular Signaling Peptides and ProteinsMaleMiddle AgedCXCL8 protein, humanDNA-Binding ProteinsGenetic MarkersInterleukin-8Intracellular Signaling Peptides and ProteinsNuclear ProteinsReceptors, Polymeric ImmunoglobulinRELA protein, humanRNA, MessengerTNFAIP3 protein, humanTranscription Factor RelATumor Necrosis Factor-alphaTumor Necrosis Factor alpha-Induced Protein 3Colonic mucosaCrohn’s diseasemRNA biomarkersMultivariate analysisUlcerative colitis

Identifiers

PMID25956706
PMCPMC4575253
OpenAlexW566648924

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.